References
- Pham HX, Mullins ME. Safety of nonsteroidal anti-inflammatory drugs in copperhead snakebite patients. Clin Toxicol. 2018;1–7.
- Lavonas EJ, Ruha AM, Banner W, et al. Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshop. BMC Emerg Med. 2011;11:2.
- Ali AJ, Horwitz DA, Mullins ME. Lack of coagulopathy after copperhead snakebites. Ann Emerg Med. 2015; 65:404–409.
- Gerardo CJ, Vissoci JRN, Brown MWJ, et al. Coagulation parameters on copperhead compared to other Crotalinae envenomation: secondary analysis of the F(ab’)2 versus Fab antivenom trial. Clin Toxicol. 2017;55:109–114.
- Gerardo CJ, Quackenbush E, Lewis B, et al. The efficacy of Crotalidae polyvalent immune Fab (ovine) antivenom versus placebo plus optional rescue therapy on recovery from copperhead snake envenomation: a randomized, double-blind, placebo-controlled clinical trial. Ann Emerg Med. 2017; 70:233–244.
- Bush SP, Ruha A-M, Seifert SA, et al. Comparison of F(ab')2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trial. Clin Toxicol. 2015;53:37–45.